Yoshie O - Search Results

1

KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis.

Higashiyama M, Kodama K, Yokouchi H, Takami K, Adachi M, Taki T, Ishiguro S, Nakamori S, Yoshie O, Miyake M. Higashiyama M, et al. Among authors: yoshie o. Cancer. 1998 Aug 1;83(3):466-74. doi: 10.1002/(sici)1097-0142(19980801)83:3<466::aid-cncr15>3.0.co;2-u. Cancer. 1998. PMID: 9690539

2

MRP-1/CD9 and KAI1/CD82 expression in normal and various cancer tissues.

Huang C, Taki T, Adachi M, Yagita M, Sawada S, Takabayashi A, Inufusa H, Yoshie O, Miyake M. Huang C, et al. Among authors: yoshie o. Int J Oncol. 1997 Nov;11(5):1045-51. doi: 10.3892/ijo.11.5.1045. Int J Oncol. 1997. PMID: 21528303

3

Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.

Sekita N, Suzuki H, Ichikawa T, Kito H, Akakura K, Igarashi T, Nakayama T, Watanabe M, Shiraishi T, Toyota M, Yoshie O, Ito H. Sekita N, et al. Among authors: yoshie o. Jpn J Cancer Res. 2001 Sep;92(9):947-51. doi: 10.1111/j.1349-7006.2001.tb01185.x. Jpn J Cancer Res. 2001. PMID: 11572762 Free PMC article.

4

Enhanced expression of LFA-3 on human T-cell lines and leukemic cells carrying human T-cell-leukemia virus type 1.

Imai T, Tanaka Y, Fukudome K, Takagi S, Araki K, Yoshie O. Imai T, et al. Among authors: yoshie o. Int J Cancer. 1993 Nov 11;55(5):811-6. doi: 10.1002/ijc.2910550520. Int J Cancer. 1993. PMID: 7503960

5

Identification of a highly specific surface marker of T-cell acute lymphoblastic leukemia and neuroblastoma as a new member of the transmembrane 4 superfamily.

Takagi S, Fujikawa K, Imai T, Fukuhara N, Fukudome K, Minegishi M, Tsuchiya S, Konno T, Hinuma Y, Yoshie O. Takagi S, et al. Among authors: yoshie o. Int J Cancer. 1995 May 29;61(5):706-15. doi: 10.1002/ijc.2910610519. Int J Cancer. 1995. PMID: 7768645

6

Mouse homologue of C33 antigen (CD82), a member of the transmembrane 4 superfamily: complementary DNA, genomic structure, and expression.

Nagira M, Imai T, Ishikawa I, Uwabe KI, Yoshie O. Nagira M, et al. Among authors: yoshie o. Cell Immunol. 1994 Aug;157(1):144-57. doi: 10.1006/cimm.1994.1212. Cell Immunol. 1994. PMID: 8039242

7

Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer.

Ueda T, Ichikawa T, Tamaru J, Mikata A, Akakura K, Akimoto S, Imai T, Yoshie O, Shiraishi T, Yatani R, Ito H, Shimazaki J. Ueda T, et al. Among authors: yoshie o. Am J Pathol. 1996 Nov;149(5):1435-40. Am J Pathol. 1996. PMID: 8909232 Free PMC article.

8

Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma.

Musha H, Ohtani H, Mizoi T, Kinouchi M, Nakayama T, Shiiba K, Miyagawa K, Nagura H, Yoshie O, Sasaki I. Musha H, et al. Among authors: yoshie o. Int J Cancer. 2005 Oct 10;116(6):949-56. doi: 10.1002/ijc.21135. Int J Cancer. 2005. PMID: 15856455 Free article.

9

High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer.

Hojo S, Koizumi K, Tsuneyama K, Arita Y, Cui Z, Shinohara K, Minami T, Hashimoto I, Nakayama T, Sakurai H, Takano Y, Yoshie O, Tsukada K, Saiki I. Hojo S, et al. Among authors: yoshie o. Cancer Res. 2007 May 15;67(10):4725-31. doi: 10.1158/0008-5472.CAN-06-3424. Cancer Res. 2007. PMID: 17510400 Free article.

10

Frequent low level expression in Ewing sarcoma family tumors and widespread absence of the metastasis suppressor KAI1/CD82 in neuroblastoma.

Aryee DN, Ambros I, Ambros PF, Muehlbacher K, Luegmayr A, Yoshie O, Kovar H. Aryee DN, et al. Among authors: yoshie o. Pediatr Res. 2002 Aug;52(2):279-85. doi: 10.1203/00006450-200208000-00022. Pediatr Res. 2002. PMID: 12149507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

301 results

Search Page